Completeness of reporting and outcome switching in trials published in Indian journals from 2017 to 2019: A cross-sectional study

Authors: Kiran Warrier, C R Jayanthi

Source: Perspectives in Clinical Research, Vol 13, Iss 2, Pp 77-81 (2022)

Subject Terms: consolidated standards of reporting trials 2010, indian medical journals, outcome switching, quality of reporting, Medicine, Medicine (General), R5-920

File Description: electronic resource

Relation: http://www.picronline.org/article.asp?issn=2229-3485;year=2022;volume=13;issue=2;spage=77;epage=81;aulast=; https://doaj.org/toc/2229-3485

Access URL: https://doaj.org/article/e982f840adaf455ba0332f0acc2fb3ae

A comparative study of efficacy and safety of alcaftadine 0.25% versus olopatadine hydrochloride 0.2% in allergic conjunctivitis at a tertiary care hospital

Authors: Akila Krishnan, C R Jayanthi, Sriya Sridhar

Source: Kerala Journal of Ophthalmology, Vol 34, Iss 3, Pp 227-233 (2022)

Subject Terms: alcaftadine 0.25% eye drops, allergic conjunctivitis, conjunctival hyperemia scale, olopatadine hydrochloride 0.2% eye drops, total ocular symptoms score, Ophthalmology, RE1-994

File Description: electronic resource

Relation: http://www.kjophthal.com/article.asp?issn=0976-6677;year=2022;volume=34;issue=3;spage=227;epage=233;aulast=Krishnan; https://doaj.org/toc/0976-6677

Access URL: https://doaj.org/article/cf352bde012f41999ecf3ecd374bfb5b

Comparative analysis of safety and efficacy of Alcaftadine 0.25%, Olopatadine hydrochloride 0.2% and Bepotastine besilate 1.5% in allergic conjunctivitis

Authors: Shruti Ayyappanavar, Sriya Sridhar, Kiran Kumar, C R Jayanthi, Suresh Babu Gangasagara, B L Sujatha Rathod, B Preethi, Preeti Mittal

Source: Indian Journal of Ophthalmology, Vol 69, Iss 2, Pp 257-261 (2021)

Subject Terms: alcaftadine, allergic conjunctivitis, bepotastine besilate, hyperaemia scale, olopatadine, total ocular symptom score (toss), Ophthalmology, RE1-994

File Description: electronic resource

Relation: http://www.ijo.in/article.asp?issn=0301-4738;year=2021;volume=69;issue=2;spage=257;epage=261;aulast=Ayyappanavar; https://doaj.org/toc/0301-4738; https://doaj.org/toc/1998-3689

Access URL: https://doaj.org/article/81438d248c8c4e759e1e8b819d97829c

Efficacy and Safety of Inosine Pranobex in COVID‐19 Patients: A Multicenter Phase 3 Randomized Double‐Blind, Placebo‐Controlled Trial

Authors: C R, Jayanthi, Swain, Ashok K, Ganga, Ranganath T, Halnor, Dnyaneshwar, Avhad, Ajit, Khan, Mohd. Saif, Ghosh, Ayan, Choudhary, Sumer Sanjiv, Yannawar, Anand Namdevrao, Despande, Shubhangi, Patel, Manish, Anne, Krishna Prasad, Bangar, Yogesh

Source: Advanced therapeutics. 5(12)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100168199017.0x000001&indx=1&recIds=ETOCvdc_100168199017.0x000001

A study to analyze the pattern, causality, severity, predictability and preventability of adverse drug reactions among patients attending department of obstetrics and gynecology at a tertiary care hospital.

Authors: C. R., Jayanthi¹, M., Bhavya Darshini¹, darshini2590@gmail.com

Source: Journal of ICT Research & Applications; 2019, Vol. 9 Issue 2, p172-177, 6p